Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 2

Epidemiology and Risk Factors in Diabetic Retinopathy and Diabetic Macular Edema

Diyabetik Retinopati ve Diyabetik Maküla Ödeminde Epidemiyoloji ve Risk Faktörleri

Pages
89–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In diabetic cases, the risk of vision loss can be significantly reduced with the control of modifiable risk factors, regular eye examinations and timely treatment practices

📌 3 Key Takeaways

🎯
Objective & Hypothesis:With the increased prevalence of diabetes mellitus, prolonged life-span and the use of insulin and oral antidiabetics, diabetic retinopathy has become one of the leading causes of loss of vision in many countries.
📊
Key Findings & Data:By 2013, the number of diabetic patients in the world is 382 million, but it is predicted that this number will reach 592 million in 2035 by an increase of 55%.
💡
Conclusion & Impact:In diabetic cases, the risk of vision loss can be significantly reduced with the control of modifiable risk factors, regular eye examinations and timely treatment practices
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

With the increased prevalence of diabetes mellitus, prolonged life-span and the use of insulin and oral antidiabetics, diabetic retinopathy has become one of the leading causes of loss of vision in many countries. By 2013, the number of diabetic patients in the world is 382 million, but it is predicted that this number will reach 592 million in 2035 by an increase of 55%. The risk factors which are related with diabetic retinopathy are diabetes duration, hyperglycemia, hypertension, lipid metabolism disorders, genetic factors, puberty and pregnancy. In diabetic cases, the risk of vision loss can be significantly reduced with the control of modifiable risk factors, regular eye examinations and timely treatment practices

Özet

Artan diabetes mellitus prevalansı, insülin ve oral antidiyabetiklerin kullanımı ile uzayan yaşam süreleri sonucu diyabetik retinopati, bir çok ülkede önde gelen görme kaybı sebeplerinden biri haline gelmiştir. 2013 yılı itibari ile dünyadaki diyabetli hasta sayısı 382 milyon iken bu sayının 2035 yılında %55 oranında artarak 592 milyona ulaşacağı öngörülmektedir. Retinopati gelişimi ile ilişkilendirilmiş risk faktörleri, diyabet süresi, hiperglisemi, hipertansiyon, lipid metabolizma bozuklukları, genetik faktörler, puberte ve gebeliktir. Diyabetik olgularda değiştirilebilir risk faktörlerinin kontrolü, düzenli göz muayeneleri ve uygun zamanda tedavi uygulamaları ile görme kaybı riski belirgin ölçüde azaltılabilir

🔖

Cite This Article

KOÇAK, N. (2018). Epidemiology and Risk Factors in Diabetic Retinopathy and Diabetic Macular Edema. Güncel Retina Dergisi, Cilt: 2 - Sayı: 2, 89–93. https://ajindex.com/articles/167584

References (15)

  1. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD et al; American Diabetes Association. Retinopathy in diabetes. Diabetes Care 2004;27:84-87
  2. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124-36
  3. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S et al. Population- based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551- 1556
  4. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78: 58-61
  5. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6
  6. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32
  7. Klein R, Klein BE, Moss SE, DeMets DL, Kaufman I, Voss PS. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 1984;119:54-61
  8. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91(12):1464-74
  9. Scanlon PH, Aldington SJ, Straton IM. Epidemiological issues in diabetic retinopathy. Middle East Afr J Opthalmol. 2013;20:293-300
  10. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in The Framingham Eye Study. Am J Ophthalmol 1978; 85: 28-34
  11. Klein R, Klein BEK, Moss SE, Linton KLP. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992;99:58-62
  12. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64
  13. Taş A, Bayraktar MZ, Erdem Ü, Sobacı G, Uçar M. Diyabetik hastalarda retinopati sıklığı ve risk faktörleri. Gülhane Tıp Dergisi 2005;47:167-174
  14. İdil A. Diyabetik retinopatide prevalans, insidans, risk faktörleri ve körlüğün önlenmesi konusunda saha çalışması, 2003
  15. Klein R, Klein BK, Moss SE, Davis MD, DeMets DL. The wisconsin epidemiologic study of diabetic retinopathy: IX.